Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in nearly two-thirds of participants, twice the rate seen with placebo.
| | | | | | | | | | Bezzy is a judgment-free space where you can get advice from real people. | | | | | | | | | | | | | | | | Until then, |  | Take care of yourself, and we'll
see you again soon! | | | | View in browser
Did a friend send you this email? Subscribe here.
To see all newsletters, click here.
Privacy | Unsubscribe
We may feature your messages to our inbox within our content. Please do not provide any personal identifiable information. Replies may be edited for length and clarity. For more, see our Privacy Policy.
Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health.
© 2025 RVO Health
1101 Red Ventures Drive
Fort Mill, SC 29707 | | | |
|
No comments:
Post a Comment